The researchers identified a significant correlation between retinal sensitivity assessed by microperimetry and the MRI and 18FDG-PET parameters found to be related to brain neurodegeneration. {read more here}

By the time cognitive symptoms of Alzheimer’s disease manifest, PET scans reveal rampant amyloid throughout the brain. A new study tracks the regional progression of this hallmark pathology from beginning to end. {read more here}

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG PET/CT in restaging and treatment response assessment of malignant disease. As cancer patients move through therapy, FDG PET/CT has proven an effective tool for assessing treatment response and updating the stage of malignancy. This AUC aims to improve utilization and guide providers across specialties in its use. (read more here)

In a paper published this month in the Journal of Neurology, Neurosurgery and Psychiatry, a team from Imperial College has shown the scale of the real world impact the scans have in investigating patients with dementia, using one of the largest group of patients to date. {read more here}